For Boston Scientific, a potential threat
Competition will get hot in cardiac market if firm's rivals merge
Boston Scientific Corp. could face tougher competition in markets for cardiac products if talks between two of its largest competitors lead to a merger, analysts and investors said. (Full article: 747 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
